Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
AMD Severity ScaleAstigmatism AssistantBarrett / SRK-T SimDiabetic Retinopathy RiskGlaucoma ProgressionGlaucoma Risk (OHTS)Graves CASHFA MD to VFI ConverterIOP Correction (CCT)LogMAR <-> SnellenMRD AssessmentROP Risk (G-ROP)SPEED Score (Dry Eye)SUN Uveitis GradingVertex Distance
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

SPEED Score (Dry Eye)

DEWS II Standardized Evaluation • SPEED™

Dryness, Grittiness or Scratchiness

Sensation of sand in the eye

Soreness or Irritation

General eye discomfort

Burning or Watering

Stinging or excessive tearing

Eye Fatigue

Tired eyes, especially after screen use

Awaiting Assessment

Quantify symptom frequency and severity to determine clinical status.

Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

Clinical Utility

Screening for Dry Eye Disease (DED) in symptomatic and asymptomatic populations.
Longitudinal monitoring of symptoms following Meibomian Gland Dysfunction (MGD) treatment.
Identifying digital asthenopia and computer vision syndrome impact.
Validating subjective improvement in clinical trials.

How it Works

Scoring Logic

DomainScaleDescription
Frequency0 - 3Never, Sometimes, Often, Constant
Severity0 - 4None, Tolerable, Uncomfortable, Bothersome, Intolerable

Clinical Cutoffs

Score 0–5Asymptomatic / Normal
Score 6–7Mild/Symptomatic (Lower threshold per Asiedu et al.)
Score ≥ 8Moderate to Severe DED (Balanced threshold per Ramalho et al.)

Clinical Pearls

Interpretation Nuance

The SPEED questionnaire is uniquely unidimensional, meaning it specifically tracks the sensory intensity of the dry eye experience. Unlike the OSDI, which measures functional limitation, SPEED is more sensitive to changes in Meibomian Gland function.

Racial & Age Statistics

Digital Devices: Students and young office workers show a significantly higher mean score (approx 8.2) due to screen-related reduced blink rate.
Gender: While DED is generally more prevalent in women, studies by Sanches et al. and Xie et al. show no significant score difference based on gender alone using the SPEED scale.
Population Means: Original English SPEED studies report means of 4.5 to 6.0, whereas language-adapted versions (Portuguese, Italian) often report higher baseline means (~7.7 - 8.2).

The Evidence

Key References

Portuguese Clinical Validation (Ramalho et al., 2025) Rasch Analysis of SPEED (Asiedu et al., 2017) Comparison of SPEED vs OSDI (Hashmani et al., 2021)

Last Comprehensive Review: 2026-07-17

In Recent Clinical News

Scanning Medical Journals

No new significant updates or guidelines matching this topic were found today. We will check again soon.